FDA suggests limits on lead in cosmetics
(HealthDay)—The U.S. Food and Drug Administration has suggested setting a limit on how much lead can be in cosmetics ranging from lipstick and eye shadow to blush and shampoo.
Dec 23, 2016
0
0
(HealthDay)—The U.S. Food and Drug Administration has suggested setting a limit on how much lead can be in cosmetics ranging from lipstick and eye shadow to blush and shampoo.
Dec 23, 2016
0
0
Federal regulators on Monday granted tentative approval to the first drug for muscular dystrophy, following an intense public campaign from patients and doctors who pushed for the largely unproven medication.
Sep 19, 2016
0
1
New research has shown that the corticosteroid deflazacort is a safe and effective treatment for Duchenne muscular dystrophy. The findings, which appear this month in the journal Neurology, could pave the way for first U.S.-approved ...
Sep 9, 2016
0
0
The reporting of trials of orlistat in the 1990s appears to have understated harms, both in the summarized results submitted to the European Medicines Agency for drug approval, and in the published papers, according to a ...
Aug 16, 2016
0
0
The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed an alternative version of the pricey medication used to treat rheumatoid arthritis and other inflammatory ...
Jul 12, 2016
0
1
Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.
Jun 28, 2016
0
15
(HealthDay)—Use of the word "breakthrough" in the U.S. Food and Drug Administration's expedited approval process could mislead doctors about the new drugs' actual benefits, researchers warn.
Apr 12, 2016
0
2
(HealthDay)—The much-touted "female libido" pill seems to cause a host of serious side effects while failing to spark much additional passion in a woman's life, a new review suggests.
Feb 29, 2016
0
4
Federal health officials on Friday expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer.
Oct 2, 2015
0
14
When prescribing newly approved drugs, physicians rely on data from clinical trials to understand the benefits and risks of those drugs for patients. But a study published in the Journal of Oncology Practice showed that for ...
Sep 23, 2015
0
11